Vom 2. bis 5. September 2018 fand in Basel die diesjährige CLINAM Konferenz unter dem Titel
„11th European and Global Summit for Clinical Nanomedicine, Targeted Delivery and Precision Medicine – The Building Blocks to Personalized Medicine“
statt.
Eine Delegation des SFB 1066 sowie Mitglieder des integrierten Graduiertenkollegs waren dort aktiv vertreten. Zudem war der SFB 1066 an der Ausrichtung mehrerer Vortragssessions (siehe unten) beteiligt.
Das vollständige Programm der CLINAM Konferenz 2018 erhalten Sie hier.
Session 6: Videos der Präsentationen
- Is There More Than Tumor Targeting? – Prof. Dr. Rudolf Zentel (Johannes Gutenberg University, Mainz)
- Engineering Innate and Adaptive Immunity with Polymeric Materials – Prof. Dr. Bruno de Geest (Ghent University)
- Protein Nanocapsules for Targeting and Controlled Release of Drugs – Prof. Dr. Katharina Landfester (Max Planck Institute for Polymer Research, Mainz)
- Polymeric Materials for Biomedical Applications – apl. Prof. Dr. Michael Gottschaldt (on behalf of Prof. Dr. Ulrich S. Schubert, Friedrich‐Schiller‐University, Jena)
Session 14: Videos der Präsentationen
- Employing the Protein Corona to Address Dendritic Cells – Prof. Dr. med. Volker Mailänder (University Medical Center of the Johannes Gutenberg University Mainz)
- Polymeric Nanogels for Antigen Delivery and Anticancer Vaccination Therapy – Prof. Dr. ir. Wim Hennink (Utrecht University)
- Plant Virus Nanoparticles for In Situ Vaccination and Treatment of Metastatic Cancer – Prof. Dr. Nicole Steinmetz (University of California)
- Targeting of Antigen Presenting Cells for Tumor Immunotherapy – Prof. Dr. med. Stephan Grabbe (University Medical Center of the Johannes Gutenberg University Mainz)
- Inhibiting macrophage infiltration to prime to the tumor vasculature and microenviornment – Prof. Dr. Twan Lammers (RWTH Aachen University)
Session 20: Videos der Präsentationen
- The Future of Clinical (Cancer) Diagnosis and its Role in Precision Therapy – Prof. Dr. med. Fabian Kiessling (University Hospital of RWTH Aachen University)
- Monitoring and Modulating Innate Immunity Using Nanomaterials – Prof. Dr. Willem Mulder (Eindhoven University of Technology)
- Imaging Biomarkers to Predict the Efficacy of Cancer Immunotherapy – PD Dr. med. Matthias Miederer (University Medical Center of the Johannes Gutenberg University Mainz)
